loadpatents
name:-0.033406972885132
name:-0.014085054397583
name:-0.0017631053924561
MONNING; Ursula Patent Filings

MONNING; Ursula

Patent Applications and Registrations

Patent applications and USPTO patent grants for MONNING; Ursula.The latest application filed is for "4h-pyrrolo[3,2-c]pyridin-4-one compounds".

Company Profile
0.24.43
  • MONNING; Ursula - Woltersdorf DE
  • Monning; Ursula - Leverkusen DE
  • Monning; Ursula - D-13342 Berlin DE
  • Monning, Ursula - Berlin DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
4h-pyrrolo[3,2-c]pyridin-4-one Compounds
App 20220298157 - SIEGEL; Stephan ;   et al.
2022-09-22
Substituted macrocyclic indole derivatives
Grant 11,440,923 - Thede , et al. September 13, 2
2022-09-13
Macrocyclic Fluorine Substituted Indole Derivatives
App 20220281891 - Ferrara; Steven J. ;   et al.
2022-09-08
Macrocyclic indole derivatives
Grant 11,401,278 - Furst , et al. August 2, 2
2022-08-02
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
Grant 11,339,157 - Siegel , et al. May 24, 2
2022-05-24
Macrocyclic fluorine substituted indole derivatives
Grant 11,286,263 - Ferrara , et al. March 29, 2
2022-03-29
Macrocyclic Indole Derivatives
App 20210292341 - Furst; Laura ;   et al.
2021-09-23
Macrocyclic Chlorine Substituted Indole Derivatives
App 20210277022 - Thede; Kai ;   et al.
2021-09-09
Substituted Macrocyclic Indole Derivatives
App 20210269456 - Thede; Kai ;   et al.
2021-09-02
Aryl Annulated Macrocyclic Indole Derivatives
App 20210253598 - Thede; Kai ;   et al.
2021-08-19
Macrocyclic Fluorine Substituted Indole Derivatives
App 20210079018 - Ferrara; Steven J. ;   et al.
2021-03-18
Hetero-1,5,6,7-tetrahydro-4h-indol-4-ones
App 20200216439 - GRAHAM; Keith ;   et al.
2020-07-09
Benzyl substituted indazoles as BUB1 inhibitors
Grant 10,350,206 - Mengel , et al. July 16, 2
2019-07-16
1H-pyrrol-3-amines
Grant 10,308,629 - Graham , et al.
2019-06-04
3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
Grant 10,227,299 - Graham , et al.
2019-03-12
Compounds
Grant 10,130,633 - Thede , et al. November 20, 2
2018-11-20
3-amino-1,5,6,7-tetrahydro-4h-indol-4-ones
App 20180155285 - GRAHAM; Keith ;   et al.
2018-06-07
Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant 9,902,727 - Scott , et al. February 27, 2
2018-02-27
N-phenyl-(morpholin-4-yl Or Piperazinyl)acetamide Derivatives And Their Use As Inhibitors Of The Wnt Signalling Pathways
App 20180042931 - THEDE; Kai ;   et al.
2018-02-15
1,3,4-thiadiazol-2-yl-benzamide Derivatives As Inhibitors Of The Wnt Signalling Pathway
App 20180044306 - THEDE; Kai ;   et al.
2018-02-15
2,3-benzodiazepines
Grant 9,890,147 - Siegel , et al. February 13, 2
2018-02-13
3-carbamoylphenyl-4-carboxamide And Isophtalamide Derivatives As Inhibitors Of The Wnt Signalling Pathway
App 20180028507 - THEDE; Kai ;   et al.
2018-02-01
Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors
App 20170305882 - MENGEL; Anne ;   et al.
2017-10-26
Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors
App 20170275269 - MENGEL; Anne ;   et al.
2017-09-28
Heteroaryl Substituted Indazoles
App 20170275268 - HITCHCOCK; Marion ;   et al.
2017-09-28
Benzyl Substituted Indazoles
App 20170275270 - BARFACKER; Lars ;   et al.
2017-09-28
Benzyl Substituted Indazoles As Bub1 Inhibitors
App 20170273980 - MENGEL; Anne ;   et al.
2017-09-28
Substituted benzylpyrazoles
Grant 9,765,058 - Hitchcock , et al. September 19, 2
2017-09-19
Heteroaryl substituted pyrazoles
Grant 9,745,285 - Mengel , et al. August 29, 2
2017-08-29
Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines
Grant 9,730,943 - Scott , et al. August 15, 2
2017-08-15
Heteroaryl substituted pyrazoles
Grant 9,682,974 - Mengel , et al. June 20, 2
2017-06-20
Inhibitors Of The Wnt Signalling Pathways
App 20170114070 - THEDE; Kai ;   et al.
2017-04-27
Novel Compounds
App 20170107212 - THEDE; Kai ;   et al.
2017-04-20
Heteroaryl Substituted Pyrazoles
App 20160326159 - MENGEL; Anne ;   et al.
2016-11-10
Novel Compounds
App 20160263122 - THEDE; Kai ;   et al.
2016-09-15
Heteroaryl Substituted Pyrazoles
App 20160168130 - HITCHCOCK; Marion ;   et al.
2016-06-16
Substituted Benzylpyrazoles
App 20160151370 - HITCHCOCK; Marion ;   et al.
2016-06-02
Heteroaryl Substituted Pyrazoles
App 20160145238 - MENGEL; Anne ;   et al.
2016-05-26
Heteroaryl Substituted Pyrazoles
App 20160145267 - HITCHCOCK; Marion ;   et al.
2016-05-26
Bicyclo 2,3-benzodiazepines And Spirocyclically Substituted 2,3-benzodiazepines
App 20160129011 - SIEGEL; Stephan ;   et al.
2016-05-12
Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
Grant 9,278,925 - Liu , et al. March 8, 2
2016-03-08
Novel Compounds
App 20160052898 - THEDE; Kai ;   et al.
2016-02-25
Heteroaryl Substituted Indazoles
App 20160046604 - HITCHCOCK; Marion ;   et al.
2016-02-18
2,3-benzodiazepines
App 20150203483 - Siegel; Stephan ;   et al.
2015-07-23
Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
Grant 9,000,026 - Liu , et al. April 7, 2
2015-04-07
Aminoalcohol Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis
App 20150080374 - Scott; William ;   et al.
2015-03-19
Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant 8,895,549 - Scott , et al. November 25, 2
2014-11-25
Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
App 20140275199 - Liu; Ningshu ;   et al.
2014-09-18
Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones For Therapy
App 20140011853 - Liu; Ningshu ;   et al.
2014-01-09
Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
App 20130330327 - Scott; William Johnston ;   et al.
2013-12-12
Aminoalcohol Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis
App 20130317004 - Scott; William Johnston ;   et al.
2013-11-28
Compounds for binding and imaging amyloid plaques and their use
App 20120237446 - Rohn; Ulrike ;   et al.
2012-09-20
Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
App 20110250135 - Schmitt-Willich; Heribert ;   et al.
2011-10-13
1-aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
Grant 7,196,202 - Blume , et al. March 27, 2
2007-03-27
1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
App 20050143439 - Blume, Thorsten ;   et al.
2005-06-30
1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
Grant 6,903,126 - Blume , et al. June 7, 2
2005-06-07
Monoclonal antibody
Grant 6,849,416 - Wiltfang , et al. February 1, 2
2005-02-01
Monoclonal antibody
App 20030166019 - Wiltfang, Jens ;   et al.
2003-09-04
1-Aryl-2-N-, S- or O-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
App 20030125550 - Blume, Thorsten ;   et al.
2003-07-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed